The core of the controversy surrounding Purdue Pharma lies in the addictive nature of OxyContin, which has been linked to the opioid epidemic affecting thousands across the United States.

Purdue Pharma has filed a new bankruptcy plan as part of a $7.4 billion settlement to resolve thousands of lawsuits over the company’s alleged role in the opioid crisis, months after the Supreme ...

When Purdue Pharma, the maker of OxyContin, declared bankruptcy in 2019, it had no debt and was worth more than a billion dollars. How is this possible? Well Purdue was facing trillions in claims ...

WASHINGTON — Purdue Pharma asked a bankruptcy judge late Tuesday to consider the latest version of its plan to settle thousands of lawsuits over the toll of the powerful prescription painkiller ...

Please send tips or suggestions to D.Thomas@thomsonreuters.com, opens new tab) Purdue Pharma's bankruptcy entered a new, possibly final phase this week when the drugmaker filed a new $7.4 billion ...

Prior to 60 Minutes' March 9, 2025 broadcast, which featured correspondent Cecilia Vega's report on the Purdue Pharma bankruptcy case, we reached out to Purdue Pharma for comment on our story ...

Purdue Pharma on Wednesday filed a new bankruptcy reorganization plan to resolve mass lawsuits alleging that the OxyContin maker and its Sackler family owners contributed to the opioid crisis.

About Purdue Pharma L.P. Purdue Pharma and its subsidiaries develop, manufacture and market medications to meet the evolving needs of healthcare professionals, patients, and caregivers.

Purdue Pharma LP has filed a new Chapter 11 plan with the US Bankruptcy Court for the Southern District of New York, pledging it will give creditors including US states and other parties more than ...